Floatz logo

Bisoprolol Fumarate

Dilated Cardiomyopathy

Peking Union Medical College HospitalUNKNOWNPhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Dilated Cardiomyopathy cohort.

Asset / SponsorPhaseRating
Ifetroban
Cumberland Pharmaceuticals
Phase 2B

Same molecule, other indications

Bisoprolol Fumarate is also rated in:

iatrogenicDormant
BB
Indicative · Phase 4
69 / 100
View asset →
coronary atherosclerosisDormant
BB
Indicative · Phase 4
69 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative · Phase 4
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →